Watch DSN: HRG shares perspective on changing OTC formulations, products
Dave Wendland, vice president of strategic relations at Hamacher Resource Group, discusses how OTC manufacturers are becoming more intentional with their new product launches.
Advertisement - article continues below
Advertisement
A new episode of Watch DSN has dropped.
In this installment, senior editor of Drug Store News, Sandra Levy, sits down for a virtual chat with Dave Wendland, vice president of strategic relations at Hamacher Resource Group.
Wendland discusses how OTC manufacturers are becoming more intentional with their new product launches—specifically in sleep and general immunity categories.
He also touches on how the growing trend of self-care has influenced manufacturers to create products that are tailored to those needs, among others.
Watch the full conversation above.
